pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Ceftazidime
drug
save

ceftazidime

Marketedupdated 5mo ago
by ACS Dobfar SpA
Approved
community read0 votes

🐶 often sniffed alongside

top 4
  • tagRecall1 co-mentions · 1 sources
  • drugMEROPENEM1 co-mentions · 1 sources
  • drugMeropenem HQ1 co-mentions · 1 sources
  • drugpolymyxin B1 co-mentions · 1 sources

all catalysts(0)

nothing on the calendar yet

Trials studying ceftazidime

  • —A Study to Learn About the Study Medicine - Zavicefta in Patients With Sepsis or Loss of Kidney Function in Japannot yet recruitingn=59
  • phase2Safety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol in Patients With Pulmonary and Extrapulmonary Infections Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complexnot yet recruitingn=120
  • phase3A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABPrecruitingn=420
  • —Real-World Study of Ceftazidime Avibactam in Chinaterminatedn=220
  • N/ACystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratifiedcompletedn=223
  • phase4Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adultscompletedn=60
  • phase3Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAInot yet recruitingn=786
  • phase4Efficacy and Safety of Ceftazidime-Avibactam (CAZ-AVI) in Chinese Participants With HAP (Including VAP)completedn=235

News(0)

no news has mentioned this drug yet

brand
Ceftazidime
generic
ceftazidime
indication
Septic Arthritis
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 1h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?